JP2016501185A5 - - Google Patents

Download PDF

Info

Publication number
JP2016501185A5
JP2016501185A5 JP2015541885A JP2015541885A JP2016501185A5 JP 2016501185 A5 JP2016501185 A5 JP 2016501185A5 JP 2015541885 A JP2015541885 A JP 2015541885A JP 2015541885 A JP2015541885 A JP 2015541885A JP 2016501185 A5 JP2016501185 A5 JP 2016501185A5
Authority
JP
Japan
Prior art keywords
substituted
alkyl
independently hydrogen
membered
heteroatoms selected
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015541885A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016501185A (ja
JP6266639B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/068866 external-priority patent/WO2014074670A1/en
Publication of JP2016501185A publication Critical patent/JP2016501185A/ja
Publication of JP2016501185A5 publication Critical patent/JP2016501185A5/ja
Application granted granted Critical
Publication of JP6266639B2 publication Critical patent/JP6266639B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015541885A 2012-11-08 2013-11-07 IL−12、IL−23および/またはIFNαの調節に有用なアルキルアミド置換ピリミジン化合物 Active JP6266639B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261723827P 2012-11-08 2012-11-08
US61/723,827 2012-11-08
PCT/US2013/068866 WO2014074670A1 (en) 2012-11-08 2013-11-07 ALKYL AMIDE-SUBSTITUTED PYRIMIDINE COMPOUNDS USEFUL IN THE MODULATION OF IL-12, IL-23 AND/OR IFNα

Publications (3)

Publication Number Publication Date
JP2016501185A JP2016501185A (ja) 2016-01-18
JP2016501185A5 true JP2016501185A5 (https=) 2016-11-24
JP6266639B2 JP6266639B2 (ja) 2018-01-24

Family

ID=49667570

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015541885A Active JP6266639B2 (ja) 2012-11-08 2013-11-07 IL−12、IL−23および/またはIFNαの調節に有用なアルキルアミド置換ピリミジン化合物

Country Status (14)

Country Link
US (1) US9540333B2 (https=)
EP (1) EP2917186B1 (https=)
JP (1) JP6266639B2 (https=)
KR (1) KR102205914B1 (https=)
CN (1) CN104903301B (https=)
AU (1) AU2013341195B2 (https=)
BR (1) BR112015009798A2 (https=)
CA (1) CA2890935A1 (https=)
EA (1) EA028052B1 (https=)
ES (1) ES2648226T3 (https=)
IL (1) IL238605A (https=)
MX (1) MX2015005561A (https=)
SG (1) SG11201503395TA (https=)
WO (1) WO2014074670A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT3495358T (lt) * 2012-11-08 2022-05-25 Bristol-Myers Squibb Company Amidais pakeisti heterocikliniai junginiai, naudingi kaip il-12, il-23 ir (arba) ifn alfa atsako moduliatoriai
TWI582077B (zh) 2013-11-07 2017-05-11 必治妥美雅史谷比公司 作爲IL-12、IL-23及/或IFNα反應調節劑之經烷基-醯胺取代之吡啶化合物
ES2702126T3 (es) 2013-12-10 2019-02-27 Bristol Myers Squibb Co Compuestos de imidazopiridazina útiles como moduladores de respuestas a IL-12, IL-23 y/o IFN alfa
KR102477063B1 (ko) * 2016-10-28 2022-12-12 브리스톨-마이어스 스큅 컴퍼니 Il-12, il-23 및/또는 ifn 알파 반응의 조정제로서 유용한 헤테로비시클릭 화합물
TW202340194A (zh) 2017-02-16 2023-10-16 美商基利科學股份有限公司 吡咯并[1,2-b]嗒𠯤衍生物
CN107857754B (zh) * 2018-01-15 2018-11-09 泰山医学院 一种化合物及其在制备预防/治疗类风湿性关节炎药物中的应用
AR117398A1 (es) 2018-03-12 2021-08-04 Abbvie Inc Inhibidores de la señalización mediada por tirosina cinasa 2
TWI842978B (zh) 2018-07-13 2024-05-21 美商基利科學股份有限公司 衍生物
SG11202112043PA (en) * 2019-04-30 2021-11-29 Celgene Corp Combination therapies comprising apremilast and tyk2 inhibitors
EP3944859A1 (en) 2020-07-30 2022-02-02 Assistance Publique Hôpitaux de Paris Method for treating immune toxicities induced by immune checkpoint inhibitors
CA3208361A1 (en) 2021-02-19 2022-08-25 Anjali Pandey Tyk2 inhibitors and uses thereof
AU2022222470A1 (en) 2021-02-19 2023-09-21 Sudo Biosciences Limited Tyk2 inhibitors and uses thereof
EP4294806A1 (en) 2021-02-19 2023-12-27 Sudo Biosciences Limited Tyk2 inhibitors and uses thereof
EP4423086A1 (en) 2021-10-25 2024-09-04 Kymera Therapeutics, Inc. Tyk2 degraders and uses thereof
WO2024257023A1 (en) 2023-06-14 2024-12-19 Alembic Pharmaceuticals Limited Tyk2 pseudokinase ligands and uses thereof

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9828511D0 (en) * 1998-12-24 1999-02-17 Zeneca Ltd Chemical compounds
EP1518855B1 (en) * 2002-06-28 2011-10-26 Astellas Pharma Inc. Diaminopyrimidinecarboxa mide derivative
KR20050019797A (ko) * 2002-06-28 2005-03-03 야마노우치세이야쿠 가부시키가이샤 디아미노피리미딘카르복사미드 유도체
JP5046943B2 (ja) * 2004-09-30 2012-10-10 テイボテク・フアーマシユーチカルズ Hiv阻害性5−置換ピリミジン
SI1814878T1 (sl) * 2004-11-24 2012-06-29 Rigel Pharmaceuticals Inc Spojine spiro-2,4-pirimidindiamina in njihova uporaba
CN101405283B (zh) * 2006-03-30 2014-06-18 泰博特克药品有限公司 Hiv抑制性5-酰氨基取代的嘧啶类化合物
WO2008009458A1 (en) * 2006-07-21 2008-01-24 Novartis Ag 2, 4 -di (arylaminio) -pyrimidine-5-carboxamide compounds as jak kinases inhibitors
SG165655A1 (en) * 2008-04-16 2010-11-29 Portola Pharm Inc 2, 6-diamino- pyrimidin- 5-yl-carboxamides as syk or JAK kinases inhibitors
HRP20161310T1 (hr) * 2008-04-16 2016-12-02 Portola Pharmaceuticals, Inc. 2,6-diamino-pirimidin-5-il-karboksamidi kao inhibitori syk ili jak kinaza
US20110071158A1 (en) * 2009-03-18 2011-03-24 Boehringer Ingelheim International Gmbh New compounds
US8367689B2 (en) * 2009-05-06 2013-02-05 Portola Pharmaceuticals, Inc. Inhibitors of JAK
EP2440204B1 (en) * 2009-06-12 2013-12-18 Bristol-Myers Squibb Company Nicotinamide compounds useful as kinase modulators
WO2011065800A2 (ko) * 2009-11-30 2011-06-03 주식회사 오스코텍 피리미딘 유도체, 이의 제조방법 및 이를 함유하는 약학적 조성물
US9139534B2 (en) * 2011-04-22 2015-09-22 Signal Pharmaceuticals, Llc Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith
LT3495358T (lt) 2012-11-08 2022-05-25 Bristol-Myers Squibb Company Amidais pakeisti heterocikliniai junginiai, naudingi kaip il-12, il-23 ir (arba) ifn alfa atsako moduliatoriai
KR102233252B1 (ko) 2012-11-08 2021-03-26 브리스톨-마이어스 스큅 컴퍼니 IL-12, IL-23 및/또는 IFNα 반응의 조절제로서 유용한 알킬-아미드-치환된 피리딜 화합물
TWI582077B (zh) 2013-11-07 2017-05-11 必治妥美雅史谷比公司 作爲IL-12、IL-23及/或IFNα反應調節劑之經烷基-醯胺取代之吡啶化合物

Similar Documents

Publication Publication Date Title
JP2016501185A5 (https=)
JP2016506369A5 (https=)
JP2016506368A5 (https=)
JP2017501236A5 (https=)
JP2015531773A5 (https=)
JP2017501237A5 (https=)
JP2015143283A5 (https=)
JP2015503621A5 (https=)
JP2015531747A5 (https=)
JP2015503622A5 (https=)
JP2010504286A5 (https=)
JP2017511357A5 (https=)
JP2016513660A5 (https=)
JP2017508782A5 (https=)
HRP20191268T1 (hr) Derivati tieno[2,3-c]pirol-4-ona kao inhibitori erk
JP2016540742A5 (https=)
JP2016532715A5 (https=)
EA201690019A1 (ru) Производное аминотриазина и содержащая его фармацевтическая композиция
JP2013537203A5 (https=)
JP2014510147A5 (https=)
JP2016518437A5 (https=)
JP2014508811A5 (https=)
JP2015514806A5 (https=)
JP2017523169A5 (https=)
JP2015536325A5 (https=)